Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases

Written By Ruchika Sharma28 July 2024 10:30 AM IST

Basel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab...

JP Nadda says Govt vigilant about quality of medicines

Written By Ruchika Sharma27 July 2024 4:26 PM IST

New Delhi: The Indian government reassured that it has a robust system in place for examining medicines and has taken necessary actions regarding...

Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI Status

Cipla beats Q1 profit view on robust demand

Written By Ruchika Sharma27 July 2024 3:07 PM IST

Hyderabad: Drugmaker, Cipla, has exceeded profit expectations for the first quarter of the fiscal year, driven by a significant increase in sales...

Lupin rolls out constipation drug Prucalopride in US after USFDA nod

JP Nadda addresses rising cancer cases, medicine affordability

Written By Ruchika Sharma27 July 2024 1:05 PM IST

New Delhi: Amid rising cancer cases in India, Health Minister JP Nadda ensured that the government is committed to providing affordable and...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma sued by Mayne Pharma for patent infringement

Written By Ruchika Sharma26 July 2024 4:03 PM IST

Mayne Pharma has initiated legal action against Sun Pharma of India, alleging patents infringement related to a certain product designed to alleviate...

Granules India packaging facility in US successfully completes USFDA inspection

Alembic Pharma successfully completes USFDA inspection for Panelav facility

Written By Ruchika Sharma26 July 2024 1:30 PM IST

Vadodara: Alembic Pharma has announced that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Mankind Pharma to acquire 100 percent stake in Bharat Serums and Vaccines for Rs 13,630 crore

Written By Ruchika Sharma26 July 2024 12:39 PM IST

New Delhi: Mankind Pharma Limited has entered into a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Limited...

Sun Pharma gets USFDA nod for alopecia areata drug Leqselvi

Written By Ruchika Sharma26 July 2024 11:34 AM IST

LEQSELVI is a new, twice daily oral selective inhibitor of Janus Kinases (JAK) JAK1 and JAK2.

Despite SC, NMC orders, rabies immunoglobulin missing in major BMC hospitals

Shilpa Medicare arm gets Morocco registration nod for Adalimumab

Written By Ruchika Sharma25 July 2024 4:23 PM IST

Hyderabad: Shilpa Medicare has announced that Shilpa Biologicals Pvt Ltd (SBPL), a wholly owned subsidiary of the Company has received registration...

Gland Pharma gets 2 USFDA observations for Dundigal facility

Written By Ruchika Sharma25 July 2024 3:28 PM IST

Telangana: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded a surprise...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Pharma Lifesciences Karnataka facility clears COFEPRIS-Mexico GMP inspection

Written By Ruchika Sharma25 July 2024 12:52 PM IST

Karnataka: Shilpa Medicare has announced that the Company's 100% subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical...

Cough syrup racket: Rs 38 crore assets of wanted accused under scanner

CDSCO may waive cough syrups from testing for export to specific countries

Written By Ruchika Sharma24 July 2024 5:15 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) is considering on a proposal to waive cough syrups from testing for export to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok